| 17 April 2024, Wednesday |

Monkeypox vaccine from Bavarian Nordic wins EU approval

Bavarian Nordic, a Danish biotechnology firm, said on Monday that the European Commission has granted clearance for its Imvanex vaccine to be sold as protection against monkeypox, as recommended by the European Medicines Agency last week (EMA).

The decision comes only one day after the World Health Organization declared the quickly growing monkeypox outbreak a global health emergency.

Bavarian’s vaccine, the only one to have won approval for the prevention of monkeypox disease in the United States and Canada, has in the EU so far only been approved to treat smallpox.

  • Reuters